-
-
-
-
-
-
-
Form F-1/A Biodexa Pharmaceuticals
-
-
-
-
-
-
-
Biodexa Announces Closing Of $6.0 Million Underwritten Public Offering, Including Full Exercise Of Overallotment Option
-
-
-
-
-
15,699 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

